Healthy high growth potential

Results

1534

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1534 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
1860
HK$11.520.8%-18.1%HK$17.7bHK$18.2630.241.1%n/aMedia
SAATVIKGL
₹402.65-3.9%n/a₹51.2b₹537.5020.847.0%n/aSemiconductors
541967
₹775.45-0.4%180.0%₹120.1b₹915.3335.827.7%0%Consumer Durables
1357
HK$4.54-6.1%-56.4%HK$20.6bHK$8.7824.231.3%2.2%Media
2315
HK$63.70-7.2%163.0%HK$62.1bHK$62.0384.241.0%n/aPharmaceuticals & Biotech
NORTHERN
RM 0.690%-3.5%RM 271.0mRM 1.0017.739.5%n/aCapital Goods
3881
HK$19.95-6.5%n/aHK$8.7bn/a5.9118.2%n/aCapital Goods
325
HK$79.4535.5%-34.9%HK$19.6bHK$81.4723.224.2%1.0%Consumer Durables
6990
HK$522.50-1.1%16.9%HK$124.9bHK$570.0552.145.1%n/aPharmaceuticals & Biotech
1729
HK$17.3011.6%31.2%HK$38.6bHK$28.7549.337.1%0.3%Capital Goods
2480
HK$13.00-4.4%-49.0%HK$2.6bHK$31.003.477.1%n/aPharmaceuticals & Biotech
3636
HK$17.20-4.3%n/aHK$2.6bHK$31.236.940.2%2.2%Materials
MONOLITH
₹1,007.5513.0%155.7%₹21.9b₹1,060.0076.435.6%n/aMaterials
2171
HK$14.39-4.9%-37.4%HK$8.6bHK$21.1958.580.6%n/aPharmaceuticals & Biotech
509496
₹1,320.254.1%68.9%₹226.8b₹1,579.7537.728.9%0.2%Capital Goods
501423
₹3,389.950.8%87.1%₹155.9b₹3,916.6788.237.3%0.09%Capital Goods
3277
HK$77.358.5%n/aHK$34.4bHK$115.35100.534.2%0.4%Tech
FWRY
ج.م19.13-0.4%41.8%ج.م65.2bج.م22.4524.527.3%n/aDiversified Financials
AXSM
US$216.27-2.1%94.6%US$11.2bUS$285.4214.661.1%n/aPharmaceuticals & Biotech
GOLDR
NOK 7.52-3.6%n/aNOK 431.1mn/a19.686.0%n/aMaterials
AAZ
UK£4.05-1.8%149.2%UK£463.1mUK£5.6835.525.9%0.7%Materials
LPK
€15.05-3.5%87.4%€365.6m€22.753.7116.6%0%Tech
CDR
zł257.800.3%1.1%zł25.7bzł234.5149.939.0%0.4%Media
TMGH
ج.م96.50-1.9%75.1%ج.م198.9bج.م141.9012.935.9%0.3%Real Estate Management and Development
Page 1 of 43